Company news: FCC, Novo, Sanofi

Share this article:
The FCC's mobile health task force convened in June to assess how to leverage mobile in the health space, and offered up its findings this week, reported MobiHealth. Among the recommendations – that the FCC should be the lead and promote greater use of mobile health technologies and that federal agencies need to collaborate to “promote innovation, protect patient safety and avoid regulatory duplication.” The initiative uses the term mobile to include remote patient monitors, software applications, body sensors that capture data, implants, patient care portals and mobile diagnostic imaging applications.

Novo Nordisk is expanding its Beijing footprint. The Danish drug maker announced Tuesday that it was investing an additional $100 million in science facilities there. The expansion includes more room and space for 70 new hires to boost its science staff to 200 employees.

Sanofi released a bout of less-bad news Tuesday: the company, which labor unions expected to lay off close to 2,500 employees, is rounding down the number to about 900 positions cut in France by 2015. The company said in a statement it expects the drop off to consist of “early retirements, mobility proposals and repositioning in France.” Bloomberg noted that Labor Unions put the at-risk total at around 1,500.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.